Woodworth Michael H, Hayden Mary K, Young Vincent B, Kwon Jennie H
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Division of Infectious Diseases, Department of Internal Medicine, Rush Medical College, Chicago, Illinois.
Open Forum Infect Dis. 2019 Jul 1;6(7). doi: 10.1093/ofid/ofz288.
The intestinal tract is a recognized reservoir of antibiotic-resistant organisms (ARO), and a potential target for strategies to reduce ARO colonization. Microbiome therapies such as fecal microbiota transplantation (FMT) have been established as an effective treatment for recurrent Clostridioides difficile infection and may be an effective approach for reducing intestinal ARO colonization. In this article, we review the current published literature on the role of FMT for eradication of intestinal ARO colonization, review the potential benefit and limitations of the use of FMT in this setting, and outline a research agenda for the future study of FMT for intestinal ARO colonization.
肠道是公认的抗生素耐药菌(ARO)储存库,也是减少ARO定植策略的潜在目标。微生物组疗法,如粪便微生物群移植(FMT),已被确立为复发性艰难梭菌感染的有效治疗方法,可能是减少肠道ARO定植的有效途径。在本文中,我们回顾了目前已发表的关于FMT在根除肠道ARO定植方面作用的文献,探讨了在这种情况下使用FMT的潜在益处和局限性,并概述了未来关于FMT用于肠道ARO定植研究的议程。